Psilocybin-Assisted Therapy for Physician Well-Being and Burnout
Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age21-70
SponsorUniversity of California, San Diego
About this trial
Through an open-label study involving a small group of UCSD physicians experiencing burnout, the investigators will evaluate the feasibility, safety, and preliminary effectiveness of PAT to reduce burnout symptoms.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
UCSD faculty physician, aged 21-70. Volunteer faculty are not included
Meets criteria for physician burnout
Experiencing symptoms of burnout for >6 months
Able to complete all required study visits
Disqualifiers
Previous inpatient psychiatric hospitalization(s)
Previously diagnosed with a psychotic disorder (schizophrenia, schizoaffective disorder, or other psychotic spectrum disorder), bipolar spectrum disorder, personality disorder (borderline personality disorder, antisocial personality disorder, or other severe personality disorders), any severe psychiatric disorder.
Exhibiting elevated suicide risk
First degree family history of psychosis or bipolar disorder
Trial design
Design model
Single group
Treatments tested in this trial
Psilocybin, [3-[2-(dimethylamino)ethyl]-1H-indol-4-yl] dihydrogen phosphate
Drug25 mg, single dose of psilocybin
Treatment groups
10 Participants
are divided into 1 treatment groupGroup A: Psilocybin-Assisted TherapyExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
Stanford Professional Fulfillment Index (PFI)
Assessment used to determine degree/severity of burnout.
Time frame
From enrollment until end of study at 12 week follow-up.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov